home / stock / dvax / dvax quote
$8.58 Last:
4.32% Change Percent:
$8.21 Open:
$8.58 Previous Close:
$8.75 High:
$8.21 Low:
921,494 Volume:
03/08/2021 11:15:54 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-03-08 | 8.21 | 8.58 | 8.75 | 8.21 | 921,494 |
2021-03-05 | 8.55 | 8.225 | 8.6 | 7.3 | 5,188,249 |
2021-03-04 | 8.42 | 8.47 | 8.67 | 7.93 | 3,587,950 |
2021-03-03 | 8.6 | 8.49 | 8.8289 | 8.3112 | 3,044,655 |
2021-03-02 | 8.95 | 8.64 | 9.03 | 8.62 | 2,486,965 |
2021-03-01 | 9.15 | 8.9 | 9.19 | 8.67 | 3,502,357 |
2021-02-26 | 9.19 | 8.75 | 10.1 | 8.635 | 9,805,980 |
2021-02-25 | 9.2831 | 8.16 | 9.6499 | 8.15 | 4,530,252 |
2021-02-24 | 9.12 | 9.38 | 9.41 | 8.7501 | 2,239,256 |
2021-02-23 | 8.98 | 9.08 | 9.21 | 8.34 | 4,071,332 |
2021-02-22 | 9.91 | 9.6 | 10.35 | 9.58 | 3,709,249 |
2021-02-19 | 9.6 | 10.07 | 11 | 9.52 | 8,623,621 |
2021-02-18 | 9.56 | 9.52 | 9.8 | 9.32 | 3,451,606 |
2021-02-17 | 9.72 | 9.82 | 9.97 | 9.55 | 3,461,795 |
2021-02-16 | 10.0005 | 9.78 | 10.01 | 9.49 | 3,718,786 |
2021-02-15 | 9.6091 | 9.74 | 10.06 | 9.3222 | 3,506,669 |
2021-02-12 | 9.6091 | 9.74 | 10.06 | 9.3222 | 3,389,657 |
2021-02-11 | 9.75 | 9.53 | 10.17 | 9.339 | 4,521,459 |
2021-02-10 | 10.7 | 9.82 | 10.9399 | 9.6 | 6,541,229 |
2021-02-09 | 11.05 | 10.6 | 11.19 | 10.42 | 5,970,122 |
Dynavax Technologies Corporation Company Name:
DVAX Stock Symbol:
NASDAQ Market:
Dynavax Technologies Corporation Website:
News, Short Squeeze, Breakout and More Instantly...
Dynavax to Present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference PR Newswire EMERYVILLE, Calif. , March 1, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commer...
Best Biotech Stocks To Buy [Or Sell] Right Now Investors looking for high returns could turn to biotech stocks . These stocks are more volatile than your usual pick. However, could this be the right time to buy biotech stocks after rising Treasury yields continue to spark a tech...
Dynavax Technologies (NASDAQ: DVAX) has been chock-full of good news so far this year. Earlier this month, the company announced plans to initiate a phase 2/3 clinical study of Clover Biopharmaceuticals' COVID-19 vaccine candidate with Dynavax's CpG 1018 adjuvant. The U.K. order...